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Summary. The proliferation of the human promonocytic 
leukemia cell line U937 is inhibited by several ether lipids, 
ether lipid analogues and by phorbol esters. An early ef- 
fect of this retardation of cell growth is the induction of 
a basic chromosomal protein, histone Hl~ Northern blot 
analysis of H1 ~ mRNA levels reveals an increase of the 
mRNA concentration within a few hours after addition 
of hexadecylphosphocholine and 1-O-octadecyl-2-O- 
methyl-rac-glycero-3-phosphocholine. This early effect 
on the synthesis of a subtype of H1 proteins precedes the 
expression of several parameters of the monocytic differ- 
entiation of U937 cells. 
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Introduction 
The alkyllysophospholipid 1-O-octadecyl-2-O-methyl- 
rac-glycero-3-phosphocholine (ET-18-OCH3) and the 
alkylphosphocholine hexadecylphosphocholine (He-PC) 
show a variety ofbiological properties. Besides activation 
of macrophages (Munder et al. 1976) and modulation of 
interleukin-1 and -2 secretion by lymphocytes (An- 
dreesen et al. 1987) these compounds possess pronounced 
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dose-dependent antiproliferative activity in vitro and in 
vivo (Berdel et al. 1981; Munder et al. 1981; Vehmeyer et 
al. 1989; Muschiol et al. 1987; Hilgard et al. 1988). 
Moreover, these compounds can induce differentiation 
of leukemic ell lines into mature myeloid cells (Honma 
et al. 1981, 1983; Hilgard et al. 1989), and some data sug- 
gest that induction of differentiation may contribute to 
the in vivo antitumoral activity of He-PC in chemically 
induced rat mammary carcinomas (Hilgard et al. 1988). 
The interaction and incorporation of these compounds 
within the cell membrane finally result in biological ef- 
fects on several cellular processes, leading to an inhibition 
of DNA replication. 
An arrest of DNA synthesis is frequently accompa- 
nied by changes of the pattern of chromosomal proteins 
(D'Anna et al. 1982; D'Incalci et al. 1986). Non-dividing, 
terminally differentiated cells, such as hepatocytes 
(Panyim and Chalkley 1969; Gabrielli et al. 1985; Gjerset 
et al. 1982) or nerve cells (Pina and Suau 1987; Pina et al. 
1984) show an increased level of the H1 histone subtype 
HI ~ Unlike other histones, the synthesis of this subtype 
does not depend on DNA replication (Zlatanova 1980), 
and it has been demonstrated in a variety of systems that 
several inhibitors of cell growth induce the de novo syn- 
thesis of this chromosomal protein (Zlatanova 1980; 
Chabanas et al. 1985; Pehrson and Cole 1980; Hall et al. 
1985; Pieler et al. 1981). 
This correlation led to the initial suggestion that the 
presence of H1 ~ may be either a prerequisite or a con- 
sequence of an inhibition of DNA replication (van 
Helden 1985). Induction of differentiation, however, has 
shown in several in vitro systems a de novo synthesis of 
HI o despite a continued DNA synthesis in these cultured 
cells (Alonso et al. 1988; Keppel et al. 1977). 
In this communication, we describe the kinetics of 
H1 ~ mRNA accumulation i the human promonocytic 
leukemia cell line U937 after addition of the alkylly- 
sophospholipid ET-18-OCH 3 and the alkylphosphocho- 
line He-PC. We demonstrate hat the early effect on H1 o 
mRNA induction precedes an increase of markers of a 
monocytic differentiation. 
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Materials and methods 
Materials. Cell-culture materials were from Gibco/BRL (Gaithers- 
burg Md.), enzymes were from Boehringer (Mannheim), chemicals 
for electrophoresis were from Serva (Heidelberg) denaturing a ents 
were purchased from Fluka (Buchs, Switzerland). Other chemicals 
were from Merck (Darmstadt). Blotting membranes were from 
Amersham (Braunschweig) and Schleicher and Schfill (Dassel). Anti 
HLA-DR, Leu3, LeuM3 and anti-(transferrin eceptor) monoclo- 
nal antibodies were obtained from Becton Dickinson (Heidelberg). 
MOl and MO2 monoclonal ntibodies were from Coulter (Kre- 
feld). Nitroblue tetrazolium and 12-O-tetradecanoylphorbol 13-
acetate (TPA) were purchased from Sigma (Mfinchen). 
Ether phospholipids and phospholipid analogues. 1-O-Palmitoyl-sn- 
glycero-3-phosphocholine (ES-16-OH), 1-O-octadecyl-2-O-methyl- 
rae-glycero-3-phosphocholine (ET-18-OCH3), hexadecylphospho- 
choline (He-PC) and hexadecylphospho-(N, N, N-trimethylamino)- 
hexanol (He-PC6) were synthesized as previously described (Eibl 
1981). The chemical structures ofthe different compounds are given 
in Fig. 1. The substances were dissolved in methanol/chloroform, 
dried under nitrogen and redissolved in serum-free RPMI-1640 me- 
dium. These stock solutions were sonicated for 10 min just before 
use.  
Phorbol ester (TPA) was dissolved in RPMI-1640 medium as a 
stock solution and was added to the cell culture (final concentration 
32 nM). 
Cell culture. Human promonocytic leukemia U937 cells were conti- 
nuously cultured in RPMI-1640 medium, supplemented with 10% 
fetal calf serum, penicillin/streptomycin (100 units/ml and 100 p.g/ 
ml, respectively) and glutamine (2mM) at 37 ~ C, 5% CO2. Cells we- 
re seeded at a density of 2 x 10 87 cells/ml and incubated in the pre- 
sence or absence of test substances for different periods of time. 
ES-16-OH 
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Fig. 1. Chemical structures of phospholipids and phospbolipid ana- 
logues 
Cells were then collected and washed in fresh medium. Cell number 
and viability was determined in a Neubauer chamber by trypan blue 
dye exclusion. 
RNA analysis. Cells were washed twice in ice-cold phosphate-buffe- 
red saline (0.14 M NaC1, 2.5 mM KC1, 8.1 mM Na2HPO4, 1.5 mM 
KH2PO4, pli 7.4) and total cellular RNA was prepared by the gua- 
nidinium isothiocynate/CsC1 method (Chirgwin et al. 1979). Cell 
homogenates in lysis buffer [4 M guanidinium isothiocyanate, 0.5% 
(w/v) N-lauroylsarcosine, 25 mM sodium citrate, 0.1 M 2-mercap- 
toethanol] were centrifuged in a Beckman SW60 rotor for 16 h at 
180 000 g (15~ The RNA sediment was dissolved in sodium dodecyl 
sulfate buffer [10 mM TRIS/HC1, pli 7.2, 5 mM EDTA, 1% (w/v) 
sodium dodecyl sulfate], precipitated with ethanol, washed several 
rimes with 80% ethanol, dried and dissolved in water. Samples of 
10 gg RNA were denatured in glyoxal (5%, v/v) and dimethylsulf- 
oxide (50%, v/v) for 1 h at 50 ~ C (McMaster and Carmichae11977). 
Denatured RNA was electrophoretically separated on 1% agarose 
gels, transferred onto nylon membranes (Amersham Hybond N) 
and hybridized with labeled DNA probes as previously described 
(Kress et al. 1986). Endogenous ribosomal RNA could be used as 
a marker, since human Hl ~ mRNA, being about 2.3 kb in length 
(Doenecke and T6njes 1986), has a size intermediate b tween 28S 
and 18S RNA, whereas main-group H1 measures around 0.7 kb 
(Eick et al. 1989). DNA probes were derived from the buman HI ~ 
gene (Doenecke and T6njes 1986), from two human main-type H1 
genes (Eick et al. 1989) and from human core histone genes (Eick 
and Doenecke, unpublished results). After labeling the DNA frag- 
ments by nick translation (Rigby et al. 1977), the probes were used 
for hybridization. 
Analysis of surface antigen expression. Quantification f surface an- 
tigen expression by flow cytometry was performed by direct immu- 
nofluorescence staining with fluorescein-isothiocyamate(FITC-con- 
jugated monoclonal antibodies against human CDI4 (LeuM3, 
MO2), CD4 (Leu4), CDll (MOI) and HLA-DR antigen. The 
transferrin-receptor antigen was quantified by indirect immuno- 
fluorescence using a FITC-conjugated goat anti-(mouse Ig) mono- 
clonal antibody. 
Nitroblue tetrazolium reduction assay. A sample of 3 x l0  6 cells were 
suspended in I ml medium. An equal volume of 0.2% nitroblue te- 
trazolium dissolved in phosphate-buffered saline was added. After 
45 min of incubation at 37 ~ C aliquots were taken and the percent- 
age of cells containing formazan deposits was determined in a Neu- 
bauer chamber. The remaining cells were pelleted and lysed by ad- 
dition of Triton X-•00 and sonication. Lysates were pelleted again 
at 2500 g. Supernatants were analyzed in a Hitachi U-2000 spectro- 
photometer at560 nm. 
Results 
Effects of phospholipids, alkylphosphocholines 
and phorbol ester on U937 cell proliferation 
U937 celts are derived from a human promonocyt ic leu- 
kemia (Sundstr6m and Nilsson 1976). They can be in- 
duced to differentiate towards monocyte-l ike cells upon 
addit ion of a number  of different compounds like phor- 
bol ester (Gidlund et al. 1981), retinoic acid (Ways et al. 
1988) interferon 7 (Ralph et al. 1983), colony-stimulating 
factors (Geissler et al. 1989) and turnor necrosis factor OE 
(Trinchieri et al. 1986). Typically, these U937 cells cease 
to proliferate and, being treated with some substances, 
become attached to culture-vessel walls. 
We have treated U937 cells with TPA, the alkyllyso- 
phospholipid ET-18-OCH87 the acyllysophospholipid 
ES-16-OH and the two alkylphosphocholines He-PC and 
He-PC 6. 
Figure 2 shows the influence of these compounds on 
U937 cell growth. During an initial phase of 24 h cell divi- 
sion does not occur. Subsequently, control cells start to 
divide resulting in a fourfold cell number at 48 h. Cells 
treated with ET- /8-OCH 87 He-PC and TPA, however, do 
not proliferate, whereas those treated with ES-16-OH 
and He-PC 6 show growth characteristics similar to con- 
trol cells. 
Effects of phospholipids, alkylphosphocholines 
and phorbol ester on H1 histone gene expression 
The synthesis of the majority of histones is tightly 
coupled to DNA synthesis. In addition to these replica- 
tion-dependent histones, a few subtypes are synthesized 
at a basal rate throughout the cell cycle. One of these re- 
placement histones is the H 1 subtype H1 ~ 
We have analyzed the expression of the human H l~ 
(Doenecke and T6njes 1986) histone gene in comparison 
with two genes coding for main-type H1 histones (Eick et 
al. 1989). Human DNA probes coding for these histones 
had been isolated previously from a human genomic li- 
brary (Eick et al. 1989). In addition, the mRNA coding 
for a core histone (H 2 A) was analyzed with the respec- 
tive human gene probe. 
Figure 3 shows Northern blots of RNA samples ob- 
tained from U937 cells, which had been treated for differ- 
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Fig. 2. Effects of varied phospholipids, phospholipid analogues and 
phorbol ester on growth kinetics of U937 cells: 1-O-octadecyl-2-O- 
methyl-rae-glycero-3-phosphocholine (ET-18-OCH3) (n) 5 lag/ml, 
hexadecylphosphocholine (He-PC) (v) 10gg/ml, hexadecylphos- 
pho-(N,N,N-trirnethylamino)-hexanol (He-PC6) (x) 10 gg/ml, 1- 
O-palrnitoyl-sn-glycero-3-phosphocholine (ES-16-OH) (o) 10 p.g/ 
ml, and 12-O-tetradecanoylphorbol 13-acetate (TPA) (me) 32 nM 
were added toU937 cells at an initial density of2 x 105 cells/ml. The 
ordinate indicates the number of viable cells/ml and the abscissa 
refers to the time interval after addition of he respective substance 
(untreated cells: o) 
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Fig. 3. Steady-state levels of mRNA coding for histone H 1~ and cell- 
cycle-dependent histone species. RNA was extracted at different 
times (top line, la) after addition of hexadecylphosphocholine 
(HePC, 25 gM). Identical amounts of RNA (10 gg) were separated 
electrophoretically, blotted and hybridized witb 3Zp-labeled probes, 
derived from genes coding for histone H1 ~ (Doenecke and T6njes 
1986), two different H1 histones (Eick et al. 1989) and an H2A core 
histone gene. The vertical arrow indicates removal of He-PC, wash- 
ing and resuspension f the cells in He-PC-free medium 
RNA coding for the replication-dependent his ones HI  ~, 
H111 and H2A reflect he growth kinetics as presented in 
Fig. 2. During the first 6 h after exposure to He-PC, the 
mRNA levels are just marginally reduced. Then the 
steady-state mRNA concentrations drop and even a re- 
moval of the growth-inhibiting compound oes not cause 
a recovery of the expression of these genes within the next 
8h. 
In contrast to the replication-dependent H 1 und H2A 
histone genes, the H1 o gene expression isstimulated upon 
addition of He-PC as early as 1 h after exposure to the 
compound. The accumulation f the H1 ~ mRNA is re- 
versed upon removal of He-PC and nearly reaches the 
basal level 8 h after resuspending the cells in control me- 
dium. 
Thus, we conclude that He-PC affects the synthesis of 
replication-dependent andreplacement histones in oppo- 
site directions. Removal of the antineoplastic compound 
leads to an immediate reversal of the HI  ~ accumulation, 
whereas the decrease of the replication-dependent his- 
tone mRNA concentration remains unchanged. These ki- 
netics hot only describe an He-PC-mediated effect on 
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gene expression, but again demonstrate that the two 
types of histone are regulated independently. 
The results obtained with ET-18-OCH 3 support he 
data described for He-PC. Figure 4 shows mRNA levels 
of U937 cells treated for different periods of time with 
ET-18-OCH 3. Again, the levels o fmRNA,  coding for the 
subtypes HI I and H1 n drop after 6-12 h of treatment, 
whereas the l vel of H1 ~ mRNA increases teadily and 
reaches a maximum 12 h after the beginning of the treat- 
ment. Continued exposure to ET-18-OCH3, which causes 
a decrease ofthe number of viable cells after 12 h of treat- 
ment, then results in a decrease of the H1 o mRNA. 
As shown in Figure 2, ES-16-OH and He-PC6 do hot 
influence the growth kinetics of U937 cells. This lack of 
antiproliferative action agrees with the Northern blot re- 
sults obtained with these substances. Figure 5 summa- 
rizes results obtained with one of these compounds, the 
acyllysophospholipid ES-16-OH. In this case, the levels 
of the replication-dependent mRNA species H 11 and H1 ii 
drop slightly during the first hours of treatment. After re- 
covery from this initial inhibitory effect, the mRNA con- 
centrations return to their initial levels. The H10 mRNA 
steady-state values, on the other hand, vary slightly dur- 
ing the initial hours of ES-16-OH treatment, but the sub- 
stance licits neither stimulatory nor inhibitory effects on 
the H1 ~ gene expression. 
Phorbol ester is known to induce differentiation of 
U937 towards macrophage-like cells (Gidlund et al. 
1981). Figure 2 demonstrates that this is accompanied by 
an inhibition of cell division. Thus, TPA treatment of 
U937 cells provides a system to monitor the correlation 
between inhibition of DNA replication and H1 ~ induc- 
tion. Figure 6 shows that the level of H1 ~ mRNA in- 
Fig.4. Levels of mRNA for H1 ~ H1 ~ and HI n in U937 cells, which 
had been exposed for different periods of time (top line, h) to the al- 
kyllysolecitihin ET-18-OCH 3 (18 gM). Identical amounts of RNA 
were electrophoresed, hybridized with probes coding for human H1 
histones ( ee above, Fig. 2)and autoradiographed 
Fig. 5. Levels ofmRNA for H1 ~ H11 and HI n in U937 cells, exposed 
for different periods f time (top line, h) to the acyllysolecithin ES- 
16-OH. Identical amounts of RNA were electrophoresed, hybrid- 
ized with the respective probes (see above, Fig. 2)and autoradiogra- 
phed. The different intensities of the three s ries are due to different 
specific activities of the three histone gene probes 
Fig.6. Effect of TPA (32 nM) on levels of mRNA coding for H1 ~ 
and for the replication-dependent H1 subtype H1 n. Each lane repre- 
sents identical amounts of RNA, extracted from U937 cellsaf ter the 
periods of TPA treatment indicated (h) above each series. At the 
time indicated bya vertical arrow, part of the cell suspension was
washed and resuspended in TPA-free medium, and RNA was ex- 
tracted from cells at different intervals thereafter (h, +).The other 
part of the cell culture remained exposed to the phorbol ester (72 h 
and 96 h) 
creases upon treatment of U937 cells with TPA. The 
mRNA concentration drastically rises at the third day of 
treatment (i. e. with a longer lag period than with the 
phospholipids described above). Washing the cells after 
48 h of TPA treatment does not interfere with the induc- 
tion process initiated by TPA, as the H10 mRNA concen- 
tration increases for the next 3 days. The H111 subtype of 
H1 shows mRNA level changes as expected for a replica- 
tion-dependent histone subspecies in decreasing upon ad- 
dition of TPA. This gradual decrease of the H1 mRNA 
concentration reflects the inhibition of cell proliferation. 
Even washing the cells after 48 h does not interrupt his 
decay. 
Effects of phospholipids, alkylphospholines 
and phorbol ester on nitroblue tetrazolium reduction 
During the course of differentiation U937 cells change 
their pattern of membrane antigen expression towards a 
monocyte-like phenotype. This includes the acquisition 
of CD14 (Hass et al. 1989; Nona et al. 1989), CD11 (Hass 
et al. 1989; Cabanas et al. 1988) and HLA-DR antigen 
(Aranzana-Seisdedos et al. 1988; Testa et al. 1988). On 
the other hand, transferrin receptors (Hass et al. 1989; 
Sheta et al. 1988) and CD4 antigen (Faltynek et al. 1989; 
Larsson et al. 1988), as typical markers for early stages of 
the myeloic lineage, are reduced or lost. 
Table 1 summarizes the influence ofTPA,  He-PC and 
ET-18-OCH 3 on surface antigen expression. These com- 
pounds in general seem to have quite similar effects. They 
463 
all enhance CD14 and CDI  1, whereas expression of CD4 
antigen and transferrin receptor is diminished. There are, 
however, striking quantitative differences in antigen ex- 
pression levels induced by these compounds. TPA, for in- 
stance, strongly enhances CD11, but has weak effects on 
CD14. In contrast, He-PC and ET-18-OCH 3 primarily 
enhance CD14 and marginally change CDl l  levels. 
After TPA treatment U937 cells lose almost 85% of 
their CD4 antigens and about 50% of their transferrin re- 
ceptors. 
He-PC treatment elicits just small changes of both 
antigens while ET-18-OCH 3 decreases transferrin recep- 
tors to about 15% of control values. 
He-PC 6 and ES-16-OH-treated cells show no signifi- 
cant difference of antigen expression pattern and quan- 
tity compared to control cell cultures. 
Though HLA-DR induction and expression could 
have been expected uring U937 differentiation (Aran- 
zana-Seisdedos et al. 1988; Testa et al. 1988) we were un- 
able to detect any membrane xpression of this antigen. 
There is some evidence that the membrane transfer mech- 
anism for cytoplasmatic HLA-DR proteins may be de- 
fective in some U937 cultures (Yunis et al. 1989). 
Effects of phospholipids, alkylphosphocholines 
and phorbol ester on nitroblue tetrazolium reduction 
Mature phagocytic ells, like macrophages and neutro- 
philes, are able to reduce nitroblue tetrazolium (Babior 
1978). In leukemia U937 cells nitroblue tetrazolium re- 
Table 1. Change of surface antigen expression on U937 after 48 h of exposure to TPA, He-PC, ET-18-OCH87 He-PC6, and ES-16-OH. 
Data represent mean fluorescence intensities determined by flow cytometry (mean of three independent experiments _+SD) 
Incubation LeuM 3 Mo 2 Leu 3 Mo I Transferrin 
(CD14) (CD14) (CD4) (CD11) receptor 
Control 4+ 3 23_+ 8 304_+21 360_+31 268_+ 5 
TPA50ng/ml 6• 2 51+ 9 46+_11 463_+29 137_+11 
He-PC 10 gg/ml 31_+ 6 111_+18 218_+28 397_+20 173_+ 9 
ET-18-OCH87 5 gg/ml 47_+11 127_+10 217_+30 385_+37 39_+13 
He-PC 6 10 gg/ml 5_+ 2 3_+ 1 316_+17 352_+10 349_+ 9 
ES-16-OH 10 Ixg/ml 0 21_+ 5 333_+20 361_+17 344_+13 
Table2. Nitroblue tetrazolium reduction capacity of U937 cells treated with TPA (50ng/ml), He-PC (5gg/ml), ET-18-OCH 3 
(2 Bg/ml), He-PC6 (10 gg/ml) and ES-16-OH (10 gg/ml) for 48 h. Cell viability under the used concentrations of compound were 
between 80 and 90% 
Incubation Positive cells ~ (%) Formazan content b(%) 
Control 1.6 + 0.6 100 
TPA 50 ng/ml 7.0 _ 1.1 131 _+ 10 
He-PC 5 ~tg/ml 17.0 + 1.3 173 _+ 11 
ET-18-OCH3 5 gg/ml 13.8 _+ 1.6 148 + 16 
He-PC 6 10 gg/ml 1.0 q- 0.6 95 • 11 
ES-16-OH 10 gg/ml 0.5 + 0.2 94 + 12 
a Percentage of cells containing formazan deposits as counted in a Neubauer chamber 
u Formazan content of cell lysates measured photometrically as percentage of control. Data represent mean of three independent 
experiments _+ SD 
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duction can be induced when cells become terminally dif- 
ferentiated (Geissler et al. 1989; Gavison et al. 1988). As 
shown in Table 2, TPA, He-PC and ET-18-OCH 3 in- 
crease the number of formazan-positive cells rive- to ten- 
fold over control cell levels. In contrast, ES-16-OH and 
He-PC 6 have no effect on formazan formation. This 
could be obtained by counting nitroblue-tetrazolium- 
positive cells in a Neubauer chamber as well as by spec- 
trophotometric measurement of formazan content in the 
supernatant of lysed cells. 
Discussion 
The human promonocytic leukemia cell line U937 is in- 
ducible towards macrophage differentiation upon addi- 
tion of several substances, uch as phorbol ester, lym- 
phokines, retinoic acid or calcitriol (Gidlund et al. 1981; 
Koeffler et al. 1980; Koeffler 1983). We have treated 
U937 cells with hexadecylphosphocholine (He-PC) and 
1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocho- 
line (ET-18-OCH3), two lipids with well-known cyto- 
static and cytotoxic properties. These compounds were 
compared with phorbol ester and two other lipids lacking 
antiproliferative activity with respect o several param- 
eters of growth inhibition and differentiation. 
The H1 histone subtype HI ~ has been first described 
as a characteristic feature of the chromatin of non-divid- 
ing cells, as in adult liver (Panyim and Chalkley 1969; Ga- 
brielli et al. 1985) or in a variety ofcell lines upon inhibi- 
tion of DNA replication (Zlatanova 1980; Chabanas et 
al. 1985; Pehrson and Cole 1980; Hall et al. 1985; Pieler 
et al. 1981). Exceptions to this apparent correlation be- 
tween a repression of DNA synthesis and an induction of 
H1 o gene expression have been described in the meantime 
in Ehrlich ascites tumor cells (Banchev et al. 1988; Bou- 
terfa et al. 1990), in erythroleukemia cells (Keppel et al. 
1977; Osborne and Chabanas 1984), in mouse teratocar- 
cinoma cells (Alonso et al. 1988) and in developing tissues 
in vivo (Gjerset et al. 1982). The human hepatoma cell 
line HepG2, for example, expresses the H1 o gene consti- 
tutively at a high level (Gabrielli et al. 1985; Hochhuth 
and Doenecke 1990), irrespective of the state of DNA 
replication (Hochhuth and Doenecke 1990). 
An established system of induction of cell differenti- 
ation in leukemia cell lines is the macrophage type of de- 
velopment of TPA-treated U937 cells (Gidlund et al. 
1981). We have shown that this tumor cell system reacts 
to phorbol ester treatment by changing three parameters: 
the proliferation rate decreases, the steady-state level of 
H1 o mRNA increases and markers of macrophage-type 
differentiation are induced. 
This correlation between an increase of the level of 
HI ~ and the differentiation f a particular cell type had 
been initially documented atthe protein level in Friend- 
virus-transformed rythroleukemia cells (Keppel et al. 
1977). In the meantime, Cheng and Skoultchy (1989) 
demonstrated a rapid induction of H 1 o mRNA and a sec- 
ond H1 mRNA (1.8 kb in length) in mouse erythroleu- 
kemia cells. In that case, the induction of both mRNAs 
was negatively regulated by the DNA-binding c-myc 
protein. Lord et al. (1990) demonstrated in murine 
myeloid cells that an increased expression of the HI ~ 
gene is an intrinsic part of the immediate arly re- 
sponse of these cells to terminal differentiation and to 
growth arrest stimuli. In that system, induction of mye- 
loid cell differentiation did not just enhance the synthesis 
of H1 ~ but the expression of a second (cell-cycle-inde- 
pendent) replacement histone gene (H3.3) was equally 
observed. An additional element of this early genetic re- 
sponse of myeloid cells was a stable induction ofjunB, a 
nuclear transcription factor. Thus, modulations in the 
structure of chromatin and direct effects on the transcrip- 
tion system parallel and precede individual steps of dif- 
ferentiation and growth arrest. 
The antineoplastic lipids He-PC and ET-18-OCH 3 in- 
duce an increased expression of the H1 o gene 3-6 h af ter 
addition to the culture medium. This early accumulation 
of H1 ~ mRNA paralMs the inhibition of DNA replica- 
tion caused by these compounds. Northern blot analysis 
of the same RNA preparations with probes for replica- 
ti n-dcpendent H1 and core histone subtypes shows the 
differential regulation of the replacement (Smith et al. 
1984) histone H1 ~ versus the replication-dependent his- 
tones, which decrease upon inhibition of DNA replica- 
tion. TPA essentially causes the same changes as the anti- 
neoplastic phospholipids on HI ~ synthesis, but with a 
prolonged lag period. 
By contrast, the two other lipids ES-16-OH and He- 
PC~, which lack antitumoral ctivity, have no effect on 
cell proliferation, H1 ~ gene expression and membrane 
antigen expression. It should be mentioned, however, 
that both compounds when compared to ET-18-OCH 3 
and He-PC, show very similar physical properties with 
respect o oil/water partition coefficients (log p values), 
critical micelle concentrations and induction ofhemolysis 
in human erythrocytes (Unger and Eibl 1990; Unger 
1989). Thus, despite the similarity of physical properties 
of the four lipids, only the two compounds with antitu- 
moral activity show the described biological effects in the 
U937 cell line. The results presented here indicate that he 
antineoplastic phospholipids provide a novel system to 
investigate his correlation. It has been shown before that 
both substances lead to an inhibition of growth (Berdel 
et al. 1981; Munder et al. 1981; Vehmeyer et al. 1989; 
Muschiol et al. 1987; Hilgard et al. 1988) and to an induc- 
tion of differentiation (Honma et al. 1981; 1983; Hilgard 
et al. 1989). The induction of expression of the H1 ~ his- 
tone gene is a very early step, which precedes the ex- 
pression of macrophage markers and parallels the anti- 
proliferative action of the phospholipid compounds. It
has been shown, on the other hand, that inhibition of rep- 
lication and H1 ~ induction are independent processes. 
Thus, we may conclude that the partial restructuring of
chromatin, as indicated by the accumulation of H1 ~ is 
one essential step contributing tothe chain of events trig- 
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